Kimberly-Clark swoops on Tylenol maker Kenvue as US deal spree accelerates
$49bn tie-up comes on frantic day of mergers and acquisitions across corporate America
$49bn tie-up comes on frantic day of mergers and acquisitions across corporate America

Kimberly-Clark buys Tylenol-maker Kenvue in more than $40bn deal

Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant

Kimberly-Clark to buy Tylenol maker Kenvue for $40bn

Kimberly-Clark to buy Kenvue in $48.7 billion deal

Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'

Acquisitions fuel pharma group’s evolution as it prepares to lose patent protection on cancer drug Keytruda

The deal will unite two giants in the over-the-counter health business, bringing together brands like Kleenex and Benadryl.

Transaction continues a frenzy of M&A activity this year in the healthcare sector

The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol.

San Diego company’s lead drug is a potential alternative to vaccines for vulnerable patients

The deal has analysts puzzled, as the US maker of Tylenol has seen sales dip after the White House linked it to autism.